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A B S T R A C T
Repeated exposure to cocaine produces structural and functional modiﬁcations at synapses from neurons in
several brain regions including the nucleus accumbens. These changes are thought to underlie cocaine-induced
sensitization. The ubiquitin proteasome system plays a crucial role in the remodeling of synapses and has re-
cently been implicated in addiction-related behavior. The ATPase Rpt6 subunit of the 26S proteasome is
phosphorylated by Ca2+/calmodulin-dependent protein kinases II alpha at ser120 which is thought to regulate
proteasome activity and distribution in neurons. Here, we demonstrate that Rpt6 phosphorylation is involved in
cocaine-induced locomotor sensitization. Cocaine concomitantly increases proteasome activity and Rpt6 S120
phosphorylation in cultured neurons and in various brain regions of wild type mice including the nucleus ac-
cumbens and prefrontal cortex. In contrast, cocaine does not increase proteasome activity in Rpt6 phospho-
mimetic (ser120Asp) mice. Strikingly, we found a complete absence of cocaine-induced locomotor sensitization
in the Rpt6 ser120Asp mice. Together, these ﬁndings suggest a critical role for Rpt6 phosphorylation and pro-
teasome function in the regulation cocaine-induced behavioral plasticity.
1. Introduction
The persistent neural and behavioral adaptations characteristic of
addiction can render an addict permanently susceptible to relapse even
years after cessation of drug use. The enduring nature of these mod-
iﬁcations suggests the involvement of memory or memory-like neuronal
remodeling (Robinson and Kolb, 1997; Russo et al., 2010; Howell et al.,
2014). Behavioral sensitization is an increase in the sensitivity to a drug
following repeated administration, characterized by enhanced loco-
motor activity, dopamine release, and the rewarding value of the drug
(Robinson and Berridge, 2008). Sensitization is argued to mediate the
transition from ordinary goal-seeking behavior to compulsive behavior
as the drug progressively elicits a much stronger dopamine response
than natural reinforcers. The involvement of protein synthesis is well
demonstrated in traditional and addiction-related memories (Schafe
and LeDoux, 2000; Hernandez et al., 2002), however the importance of
protein degradation in memory and addiction-related plasticity and
behavior has only recently been studied.
The ubiquitin proteasome system (UPS) plays a major role in the
development, maintenance and remodeling of synaptic connections
(Mabb and Ehlers, 2010; Hamilton and Zito, 2013). The 26S protea-
some, which degrades ubiquitinated proteins, is a large multi-subunit
energy-dependent protease formed by the co-assembly of a 20S pro-
teasome catalytic core and 19S cap regulatory particle (RP) (Hershko
and Ciechanover, 1998). We and others recently found a novel form of
regulation for the 26S proteasome involving CaMKIIα, a key kinase
involved in neuronal plasticity underlying learned behaviors. CaMKIIα
phosphorylates the ATPase 19S (RP) subunit of the 26S proteasome,
Rpt6, at serine 120 (S120) in an activity-dependent fashion to control
the activity and distribution of proteasomes in neurons (Djakovic et al.,
2009; Bingol et al., 2010; Djakovic et al., 2012). We have previously
shown that Rpt6 is involved in the regulation of synaptic strength and
activity-dependent generation of new spines (Djakovic et al., 2012;
Hamilton et al., 2012). Here, we utilize recently generated Rpt6 S120D
phospho-mimetic knock in (KI) mice (serine 120 to aspartic acid) to
examine the importance of Rpt6 phosphorylation on cocaine-induced
locomotor sensitization. We found that cocaine increases Rpt6 S120
phosphorylation in cultured neurons, the nucleus accumbens (NAc),
and the prefrontal cortex (PFC) of wild type (WT) mice. Furthermore,
repeated cocaine administration elevated proteasomal activity in both
the NAc and PFC in WT mice but not in Rpt6 S120D KI mutant mice.
Cocaine-induced locomotor sensitization was completely absent in the
Rpt6 S120D KI mice. Together, these ﬁndings implicate a critical role
for Rpt6 phosphorylation and proteasome function in the regulation of
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cocaine-induced behavioral sensitization.
2. Materials and methods
2.1. Generation of S120D Knockin mice
We generated Rpt6 phospho-mimetic (ser120 to aspartic acid;
S120D) KI mice (iTL; www.genetargeting.com). The strategy for gen-
erating the KI mice is described in Fig. 2. The targeting vector was
linearized and transfected by electroporation into BA1 (C57Bl/
6 × 129/SvEv) (Hybrid) embryonic stem cells. Selected clones were
expanded for southern blot analysis to identify recombinant ES clones
(data not shown). The ES clones were microinjected into C57BL/6
blastocysts. After germline transmission, the Neo cassette was removed
by mating to C57BL/6 FLP mice. Tail DNA was analyzed by PCR to
identify heterozygous mice and verify deletion of the Neo cassette.
Mutant heterozygous mice were backcrossed to C57BL/6. By visual
inspection, Rpt6 S120D homozygous mutants (conﬁrmed by PCR and
sequencing) obtained by crossing heterozygous mutants, displayed
normal body size, feeding, and mating behaviors. The intercross of
heterozygotes resulted in production of wild-type, heterozygous, and
homozygous oﬀspring at the expected 1:2:1 Mendelian ratio. All pro-
cedures were approved by the UCSD IACUC and compliant with the
NRC Guide.
2.2. Antibodies and reagents
Mouse mAb Rpt6 (Enzo mAb P45-110, BML-PW9265-0025), mAb
20S (Enzo mAb MCP231, BML-PW8195-0025), tubulin (Sigma T9026),
mAb CaMKIIα (Abcam ab2725), tyrosine hydroxylase (Millipore
AB152), MAP2 (Abcam AB5392) and custom rabbit pAb phospho-spe-
ciﬁc Rpt6 S120 (Djakovic et al., 2012) antibodies were used. N-suc-
cinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin (Suc-LLVY-AMC)
substrate was used (BACHEM). Methamphetamine HCl (Sigma M8750),
and atomoxetine HCl (TCI Chemicals A2357) were dissolved in water
and citalopram HBr (Enzo BMC-NS112) was dissolved in ethanol. Co-
caine HCl (Sigma) administered during behavioral assessment was
dissolved in physiological saline to a dose of 15 mg/kg (salt weight) and
administered i.p. (10 ml/kg).
2.3. Neuronal cultures
High Density Rat dissociated cortical neurons from postnatal day 1
pups of either sex were plated onto poly D-lysine-coated 6-well plastic
dishes at ~500,000 cells per well (cortical cultures) and were main-
tained in B27 supplemented Neurobasal media (Invitrogen) until
≥14 d in vitro (DIV), as previously described (Djakovic et al., 2009).
2.4. Proteasome activity assays
Proteasome activity was measured as previously described (Kisselev
and Goldberg, 2005) with slight modiﬁcations. Brieﬂy, cultured neu-
rons were incubated for 24 h in either plain media (control), or media
containing Cocaine (1 μm, 5 μm), methamphetamine (500 μM), citalo-
pram (25 μM) or atomoxetine (25 μM). Cultured neurons and brain
tissues were then lysed or dounced, respectively, in Aﬃnity Puriﬁcation
Buﬀer (APB) (25 mM Hepes–KOH, pH 7.4, 10% glycerol, 5 mM MgCl2,
1 mM ATP, and 1 mM DTT) (Besche and Goldberg, 2012), and lysates
were cleared by centrifugation. Equal amounts of protein were used as
inputs for the peptidase assay. Chymotrypsin-like activity was mon-
itored over time using Suc-LLVY-AMC substrate. Assays were run in
triplicate at 37 °C using a microplate ﬂuorimeter (HTS7000 Plus,
Perkin-Elmer) with excitation and emission ﬁlters of 360 nm and
465 nm, respectively. Kinetics data was taken every 60 s for 2 h using
96-well microplates (Costar). The data was averaged and plotted to ﬁnd
the kinetic rates of the chymotrypsin-like activity.
2.5. Western blot analysis
Equal or increasing amounts of protein lysates from dissociated
cortical neurons as well as brain lysates were resolved by SDS-PAGE
and probed with primary antibodies for total Rpt6, phospho-Rpt6 S120,
CaMKIIα, and tyrosine hydroxylase. Resulting blots were digitized and
band intensities quantitated using NIH ImageJ. For quantiﬁcation of
total phospho-Rpt6 S120 levels, band intensities in each condition were
normalized to total Rpt6 band mean intensity from the same sample.
Experimenters were blinded to condition during data collection and
analysis.
2.6. qPCR
Total RNA was extracted from dissected samples or cultured neu-
rons using Hybrid-R RNA puriﬁcation kit (GeneAll Biotechnology).
Puriﬁed RNA samples were reverse transcribed by using the
SuperScript-IV First-strand cDNA synthesis kit (Invitrogen). qRT-PCR
was performed by using TaqMan Gene Expression Assay Kit (Applied
Biosystems). All TaqMan probes were purchased from Applied
Biosystems and are as follows: TH (Mm00447557_m1) and glycer-
aldhyde-3-phosphate dehydrogenase (GAPDH; Mm99999915_g1).
Target ampliﬁcation was performed by using ViiATM 7 Real-Time PCR
System (Applied Biosystems). The relative mRNA expression levels
were calculated via a comparative threshold cycle (Ct) method using
GAPDH as an internal control: DCt = Ct (gene of interest)− Ct
(GAPDH). The gene expression fold change was normalized to the
control sample and then was calculated as 2-DDCt (Schmittgen and
Livak, 2008).
2.7. Behavioral sensitization
40 adult Rpt6 S120D and WT mice were used for behavioral ex-
periments. All animals were group housed. The vivarium was main-
tained on a 14:10 light:dark schedule. Mice had unrestricted access to
food and water. All mice were handled for ﬁve days prior to behavioral
assessment. Mice were then habituated to testing chambers during two,
1 h sessions (30 min per side). Testing was conducted during the light
phase (Howell et al., 2014). Two-sided polycarbonate chambers, each
side distinct in appearance and ﬂoor, bisected by an opaque acrylic wall
were paired with saline or drug (counterbalanced). Mice were divided
into four groups: S120D-Cocaine, WT-Cocaine, S120D-Saline, and WT-
Saline. Sensitization was induced during four sessions of cocaine ad-
ministration (as in Fig. 1C or 3A). All animals ﬁrst received an injection
of saline (10 ml/kg) and were placed in the saline-paired side of the
chamber for 15 min. Mice were removed, given an injection of either
cocaine (S120D-Cocaine, WT-Cocaine groups) or saline (S120D-Saline,
WT-Saline groups) and immediately placed in the drug-paired side of
the chamber for 15 min.
2.8. Histology
24 h post-sensitization, mice were given a ﬁnal injection of cocaine
(S120D-Cocaine, WT-Cocaine) or saline (S120D-Saline, WT-Saline) in
their home cage. 30 min later, mice were anesthetized (isoﬂurane) and
decapitated for fresh tissue collection. For whole brain experiments,
brains were ﬂash frozen in liquid nitrogen and stored at −80 °C. For
experiments targeting the NAc and PFC, brains were removed and
frozen on dry ice. 1 mm coronal sections were obtained using an acrylic
matrix (A/P: 2.10–1.10; Braintree Scientiﬁc). 1 mm punches (Miltex)
were then taken from the NAc (M/L:± 0.5, D/V: 2.0) and PFC (M/
L:± 1.25, D/V: 4.25), ﬂash frozen in liquid nitrogen and stored at
−80 °C.
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2.9. Data analysis
For western blot experiments statistical signiﬁcance was determined
using unpaired Student t-tests (Prism). Behavioral data were entered
into a multivariate ANOVA (SPSS). For proteasome activity assays,
ANOVA was performed, or Mann-Whitney U test (for non-parametric
data). If a signiﬁcant omnibus comparison or group × time/session
interaction was achieved, post-hoc comparisons were made using
Fisher's protected least signiﬁcant diﬀerence (PLSD). For all
experiments, signiﬁcance was set at a level of p≤ 0.05.
3. Results
3.1. Cocaine increases Rpt6 S120 phosphorylation and proteasome activity
It is known that cocaine activates CaMKIIα through T286 phos-
phorylation (Anderson et al., 2008). Since we discovered that CaMKIIα
phosphorylates Rpt6 at ser120 which increases proteasome activity
(caption on next page)
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(Djakovic et al., 2009; Djakovic et al., 2012), we wondered whether
cocaine could regulate Rpt6 S120 phosphorylation and proteasome
activity. We examined Rpt6 S120 phosphorylation and proteasome
activity in lysates from cultured neurons treated with increasing
amounts of cocaine. Measuring proteasome peptidase activity, we
found that treatment with 5 μM cocaine signiﬁcantly increased pro-
teasome activity (ANOVA F(2,22) = 11.81, p= 0.001; unpaired Stu-
dent's t-test: t(16) = 5.455, p < 0.001) (Fig. 1A). While we observe an
increase in Rpt6 phosphorylation after 1 μM cocaine treatment (Fig. 1B,
C), we only observe a concomitant and signiﬁcant increase in protea-
some activity after 5 μM treatment (ANOVA F(2,9) = 20.4, p < 0.001;
unpaired Student's t-test: t(6) = 5.942, p= 0.001). To determine if
monaminergic systems were involved in this eﬀect, we utilized a second
dopamine re-uptake inhibitor, methamphetamine (which also inhibits
serotonin and norepinephrine re-uptake, yet does not interact with
sodium ion channels), a serotonin-speciﬁc re-uptake inhibitor (citalo-
pram) as well as a norepinephrine re-uptake inhibitor (atomoxetine) to
treat cultured neurons. We found that treatment with methampheta-
mine (500 μM) produced an increase in proteasome activity, similar to
that of cocaine (ANOVA F(3,28) = 4.204, p= 0.0142; unpaired Stu-
dent's t-test: t(18) = 4.34, p < 0.001), however neither citalopram
(25 μM) (t(16) = 0.3462, p= 0.734) nor atomoxetine (25 μM) (t(15)
= 0.8767, p= 0.395) had any signiﬁcant eﬀect (Fig. 1D). Additionally,
we observe signiﬁcant expression of tyrosine hydroxylase in our dis-
sociated neuron cultures, both via western blot (Fig. 1E) as well as by
qPCR (Fig. 1F), which suggest the presence of dopaminergic systems.
We additionally evaluated whether cocaine would produce similar ef-
fects on Rpt6 S120 phosphorylation and proteasome activity when
administered to mice (i.p.). We treated mice with either cocaine or
saline for 6 days (Fig. 1G). Rpt6 S120 phosphorylation (Mann-Whitney
U test: U= 0, p= 0.029) and proteasome activity (Mann-Whitney U
test: U= 0, p= 0.029) was signiﬁcantly increased in WT whole brains
from mice treated with cocaine compared to saline (Fig. 1H, I, J). Taken
together, we show that cocaine concomitantly increases Rpt6 phos-
phorylation and proteasome activity.
3.2. Generation of Rpt6 S120D Knockin (KI) mice
To begin to assess the biological relevance of Rpt6 (PSMC5) S120
phosphorylation, we generated genetically modiﬁed mice encoding a
serine 120 to aspartic acid phospho-mimetic mutant of the Rpt6 protein
(Fig. 2A), which can be distinguished from the wild type Rpt6 gene by
PCR-based genotyping (Fig. 2B and C). Rpt6 S120D homozygous KI
mice expressed similar levels of Rpt6 protein as wild-type (+/+) mice.
By visual inspection, Rpt6 S120D homozygous mutants were indis-
tinguishable from wild type littermates and displayed normal body size,
feeding, and mating behaviors. We found that our custom pS120
phospho-speciﬁc antibody, which does not recognize Rpt6 S120A mu-
tant protein (Djakovic et al., 2012) and slightly cross reacts with the
Rpt6 S120D which is likely due to the negative charge of the aspartic
acid residue (Fig. 2D). Gross brain anatomy in Rpt6 S120D homozygous
mice was comparable to wild-type (Fig. 2E).
3.3. Rpt6 S120 phosphorylation and peptidase activity is increased in NAc
and PFC in cocaine treated wild type mouse brains, but not in S120D mutant
mice
Major biochemical and structural changes in both the NAc as well as
the PFC are associated with cocaine sensitization (Robinson and Kolb,
1997). To determine if cocaine increases Rpt6 phosphorylation and
proteasome activity speciﬁcally in the NAc and PFC, mice were ad-
ministered ﬁve cocaine (15 mg/kg, i.p.) or saline treatments across
6 days (Fig. 3A) and then lysates were extracted from tissue punched
from the NAc and PFC of both WT and Rpt6 phospho-mimetic S120D
mice (Fig. 3B). Western blot analysis and peptidase assays were per-
formed. In WT mice, cocaine administration increased Rpt6 phos-
phorylation in the NAc in comparison to treatment with saline (Fig. 3E).
This increase is also correlated with a signiﬁcant enhancement in pro-
teasome activity in the NAc (U= 0, p= 0.029) (Fig. 3C). Interestingly,
however, cocaine-induced increases in proteasome activity was not
observed in the NAc of S120D mice (U= 7, p= 0.886) (Fig. 3D). A
similar trend was observed in PFC. Cocaine increased Rpt6 S120
phosphorylation in PFC in cocaine-treated WT mice (Fig. 3H), which
correlated with increased peptidase activity (U= 0, p= 0.029)
(Fig. 3F). As in the NAc, this increase was occluded in the PFC of S120D
mutated mice, as no diﬀerence was observed between mice adminis-
tered cocaine or saline (U= 8, p > 0.999) (Fig. 3F). Taken together,
we show that cocaine concomitantly increases Rpt6 phosphorylation
and proteasome activity speciﬁcally in the NAc and PFC and that the
cocaine-induced increase in proteasome activity is occluded in the Rpt6
S120D mutant.
3.4. Behavioral sensitization is completely absent in Rpt6 S120D KI mutant
mice
Locomotor sensitization to cocaine (15 mg/kg i.p.) was assessed in
four groups of mice; S120D mice administered cocaine and saline
(S120D-Cocaine (n = 11) and S120D-Saline (n = 5), respectively) and
WT littermates administered cocaine and saline (WT-Cocaine (n = 18)
and WT-Saline (n = 6), respectively). Baseline activity (prior to any
injections; habituation (H), Fig. 4A) did not diﬀer between groups [F
(3,36) = 0.037, p= 0.99)]. Diﬀerences emerged during subsequent
sessions [Fig. 4A, F(3,36) = 5.79, p < 0.005]. While locomotor ac-
tivity increased in WT-Cocaine mice across repeated injections, activity
levels of S120D-Cocaine mice remained constant (Fig. 4A, Fisher's
PLSD, p= 0.007). Further, locomotor activity did not diﬀer between
S120D-Cocaine mice and groups administered saline (S120-Cocaine/
S120D-Sal, p= 0.59; S120D-Cocaine/WT-Saline, p= 0.36). There
were no between group diﬀerences during the ﬁrst session of cocaine
(or saline) administration [Fig. 4B, F(3,36) = 0.778, p= 0.51].
Fig. 1. Cocaine increases Rpt6 S120 phosphorylation and proteasome activity via the dopaminergic pathway. A, Dissociated cortical neurons (DIV > 17) were treated with vehicle or
cocaine (1 and 5 μM, 24 h) and chymotrypsin-like proteasome activity was measured in lysates with the ﬂuorogenic substrate Suc-LLVY-AMC. Graph depicts rate substrate cleavage
(mean ± S.E. ﬂuorescence) normalized to control-treated neurons. Cocaine treatment (5 μM, 24 h) signiﬁcantly increases proteasome activity (*, ANOVA: F(2,22) = 11.81, p= 0.001;
unpaired Student's t-test: p < 0.05, n = 9). B, Representative western blot of lysates in (A) probed with phosphor-Rpt6 pS120, total Rpt6, phospho-CaMKIIα T286, total CaMKIIα, and
20S core antibodies. C, Quantiﬁcation of phosphor-Rpt6 blot in (B). Cocaine increases Rpt6 S120 phosphorylation in a dose dependent-manner. D, Dissociated cortical neurons
(DIV > 17) were treated with vehicle, methamphetamine (500 μM, 24 h), SERT inhibitor citalopram (25 μM, 24 h) or NET inhibitor atomoxetine (25 μM, 24 h) and chymotrypsin-like
proteasome activity was measured in lysates with the ﬂuorogenic substrate Suc-LLVY-AMC. Graph depicts rate substrate cleavage (mean ± S.E. ﬂuorescence) normalized to control-
treated neurons. Methamphetamine treatment signiﬁcantly increases proteasome activity (*, ANOVA: F(3,28) = 4.204, p= 0.014; unpaired Student's t-test: p < 0.001, n = 9), while
neither citalopram (p= 0.73, n = 6) nor atomoxetine (p= 0.40, n = 6) had any signiﬁcant eﬀect. E, Representative western blot of dissociated cortical neuron lysates (DIV = 21)
compared to whole brain lysate and probed with tyrosine hydroxylase antibodies (Millipore AB152) to show relative expression levels of TH in dissociated cortical neuron cultures. F,
qPCR of lysates from dissociated cortical neurons (DIV = 21) and whole brain cortex show expression of tyrosine hydroxylase in both lysates, indicating monaminergic systems in
dissociated cortical neuronal cultures. G, Schematic of drug administration protocol. After a habituation period on day 1 and 2, cocaine (15 mg/kg, i.p) or saline was administered on days
3 thru 7 and a ﬁnal injection was delivered on day 8 immediately prior to brain extraction. H,Whole brain lysates were prepared and proteasome activity and Rpt6 phosphorylation were
examined as above. Proteasome activity increased in brains of cocaine-injected animals relative to saline (*, p < 0.05, Mann-Whitney U test; U= 0, p= 0.029, n = 4). I, Representative
western blot of lysates in (H) probed with phospho Rpt6 pS120, total Rpt6 and 20S core antibodies shows that a concomitant increase in Rpt6 S120 phosphorylation occurs in cocaine-
treated animals when compared to saline. J, Quantiﬁcation of phosphor-Rpt6 blot in (I) shows a signiﬁcant increase in Rpt6 phosphorylation in cocaine treated animals.
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Importantly, there was no diﬀerence in the acute (Day 1) response to
cocaine between S120D and WT mice (p= 0.76). Session 4 locomotor
activity was elevated in WT-Cocaine mice compared to all other groups
[Fig. 4C, F(3,36) = 4.57, p < 0.01; S120D-Cocaine/WT-Cocaine
p= 0.01]. Interestingly, locomotor activity did not diﬀer between
S120D-Cocaine mice and either saline group (S120D-Cocaine/S120D-
Saline, p= 0.64; S120D-Cocaine/WT-Saline, p= 0.67). Sensitization
was assessed as a diﬀerence between session 1 (acute) and session 4
(sensitized) activity (Fig. 4D). There were signiﬁcant group diﬀerences
[F(3,36) = 3.70, p < 0.0.05]. S120D-Cocaine mice did not sensitize,
Fig. 2. Generation of Rpt6 S120D Knockin (KI) mice. A, Schematic of targeting strategy. Genomic DNA structure of psmc5 (Rpt6) region is shown. The targeting vector was designed such
that the long homology arm (LA) extends 5.98 kb 3′ to the ﬁrst point mutation (asterisk; AG→ GA, S120D) in exon 5. The FRT ﬂanked Neo resistance cassette was inserted 463 bp 5′ to
the point mutation. The short homology arm (SA) extends 2.79 kb 5′ to the FRT ﬂanked Neo cassette. B, Tail genomic DNA was analyzed by PCR screening for genotyping and to verify
deletion of the Neo cassette. C, Electropherograms conﬁrming the presence of the mutation in homozygous Rpt6 S120D mutant male mice. D, Western blot analysis of aﬃnity puriﬁed 26S
proteasomes from Rpt6 S120D KI mice and wt littermates and probed with phospho Rpt6 pS120, total Rpt6 and 20S core antibodies. E, Representative images of Nissl stained ﬁxed whole
brain coronal sections of 60 day old mice.
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whereas WT-Cocaine mice demonstrated robust sensitization (Fig. 4D;
p= 0.008). Again, there were no activity diﬀerences between S120D-
Cocaine mice and saline control groups (S120D-Cocaine/S120D-Saline,
p= 0.87; S120D-Cocaine/WT-Saline, p= 0.79).
4. Discussion
In order to assess the importance of proteasome-dependent protein
degradation in addiction-related behavior we generated a novel line of
mutant mice with a single point mutation on a single subunit of the 26S
Fig. 3. Cocaine increases Rpt6 phosphorylation and proteasome activity in NAc and PFC in wildtype but not Rpt6 S120D KI mutant mice. A, Schematic of drug administration protocol.
After a habituation period on days 1 and 2, cocaine (15 mg/kg, i.p) or saline was administered on days 3–7 and a ﬁnal injection was delivered on day 8 immediately prior to brain
extraction. B, 1 mm coronal sections were obtained using an acrylic matrix and tissue punches were taken from NAc and PFC. Depicted are the centers of individual punches (black dots),
the arithmetic mean of the punch location (red dot), and average extent of all punches (dashed line). Lysates were prepared and chymotrypsin-like proteasome activity and Rpt6
phosphorylation was examined. C thru E (NAc) and F thru H (PFC), Cocaine increases proteasome activity in NAc and PFC of wildtype (C, F) but not Rpt6 S120D KI mutant mice (D, G),
measured by rate of substrate cleavage (mean ± S.E. ﬂuorescence) normalized to saline-treated animals (*, p < 0.05, Mann-Whitney U test; n = 4: NAc: U= 0 and 7, p= 0.029 and
0.886 for wildtype and Rpt6 S120D cocaine to saline-treatments, respectively; and *, p < 0.05, Mann-Whitney U test; n = 3: U= 0 and 8, p= 0.029 and 0.999 for wildtype and Rpt6
S120D cocaine to saline-treatments, respectively). E, H, Representative western blot of lysates from wildtype NAc (E) and PFC (H) probed with phospho Rpt6 pS120, total Rpt6, and
tubulin antibodies shows a dramatic increase in the NAc and slight increase in PFC for Rpt6 S120 phosphorylation in cocaine-treated animals compared to saline-treated controls. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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proteasome. Phosphorylation of the 19S ATPase subunit Rpt6 at S120
has been shown to be regulated by CaMKIIα in an activity-dependent
manner, and increases in Rpt6 S120 phosphorylation correlated with
increased proteasome activity (Figs. 1 and 3; Djakovic et al., 2012).
Here, we demonstrate that Rpt6 phosphorylation at S120 is critical for
cocaine-induced sensitization, a prominent addiction-related behavior.
In cell culture, we observe a cocaine-induced signiﬁcant increase in
proteasome phosphorylation as well as chymotrypsin-like activity.
Furthermore, we observed similar eﬀects treating with methampheta-
mine, and not SERT-speciﬁc nor NET-speciﬁc inhibitors produced a
similar eﬀect. Together with TH immunoreactivity observed via wes-
tern blot, as well as veriﬁcation of mRNA expression via qPCR, we can
conclude that this cocaine-induced response involves the dopaminergic
system. In Rpt6 S120D mutant mice, Rpt6 S120 phosphorylation is
locked in the phospho-mimetic state, behavioral sensitization to co-
caine is completely absent, indicating the importance of dynamic reg-
ulation of Rpt6 S120 phosphorylation.
When treated with multiple administrations of cocaine, locomotor
activity of S120D mice did not diﬀer locomotor activity from mice re-
ceiving saline. It is important to note that while sensitization was
blocked in these mice, the acute response to cocaine did not diﬀer from
WT animals (Fig. 4B). Thus, we are able to conclude that there is a
disruption in nonassociative memory rather than simply an impaired
response to cocaine.
Our results tend to support an interactionist view of memory and
addiction (Volkow et al., 2002; Carmack et al., 2013). According to this
model there are distinguishable associative and nonassociative com-
ponents of addiction, and the molecular mechanisms and neural sub-
strates underlying these processes may overlap with those involved in
canonical forms of memory (Anagnostaras and Robinson, 1996;
Anagnostaras et al., 2002; Russo et al., 2010). Here, we demonstrate
that behavioral changes reﬂecting the nonassociative component of
addiction, e.g. sensitization, that result from repeated drug adminis-
tration are aﬀected by changes to cellular plasticity mediated by the
ubiquitin proteasome system.
Other recent studies have begun to investigate the importance of the
ubiquitin proteasome system in addiction, speciﬁcally the eﬀects of
protein degradation inhibition during the development and expression
of conditioned place preference (a task that models drug-seeking) and
sensitization (Massaly et al., 2013; Ren et al., 2013). Development, but
not expression of morphine-induced CPP was impaired by administra-
tion of a UPS inhibitor (Massaly et al., 2013). Similarly, treatment with
a proteasome inhibitor during the induction of sensitization to mor-
phine produced impairment (Massaly et al., 2013). Ren et al. (2013)
investigated the eﬀects of co-administration of a protein synthesis in-
hibitor and inhibitor of the UPS on cocaine-induced conditioned place
preference. Co-treatment with a UPS inhibitor reversed the memory
impairments typically produced by the administration of the protein
synthesis inhibitor alone (Ren et al., 2013). Understanding the role of
protein degradation during addiction is a young area of investigation
Fig. 4. Disruption of locomotor sensitization in S120D mice. A, S120D mice did not sensitize across 4 days of cocaine administration (n = 18 WT-Cocaine, n = 11 S120D-Cocaine, n = 6
WT-Saline, n = 5 S120D-Saline). The average distance traveled for each session (± SEM) is depicted. All mice showed a similar level of activity during habituation and day 1. However,
during days 2–4, locomotor activity of WT-Cocaine mice was elevated compared to S120D-Cocaine mice and mice receiving saline (15 mg/kg, i.p; p < 0.005). B, Locomotor activity
during day 1. The data represent the distance traveled per minute of the session (± SEM). There were no diﬀerences between the four groups (p= 0.51). C, Locomotor activity during
day 4. Distance traveled per minute of the session (± SEM) is depicted. While the response to cocaine was elevated in WT-Cocaine mice, S120D-Cocaine mice did not exhibit locomotor
activity diﬀerent from saline groups (WT-Cocaine, S120D-Cocaine Fisher's PLSD p= 0.01; S120D-Cocaine, WT-Saline, S120D-Saline Fisher's PLSD p > 0.5). D, Sensitization was
measured as the diﬀerence in locomotor activity between day 4 (sensitized response) and day 1 (acute response). The average diﬀerence in distance traveled (± SEM) per group is
shown. S120D-Cocaine mice did not develop sensitization and did not diﬀer from mice that received saline (S120D-Cocaine/S120D-Saline, S120D-Cocaine/WT-Saline, p > 0.7 WT-
Cocaine mice displayed sensitized, elevated locomotor activity that diﬀered from S120D-Cocaine mice (p < 0.01).
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and many questions remain. The present study advances our current
understanding by utilizing the ﬁrst discrete mouse-model of altered
proteasome function. This is important, as many of the previous studies
have relied upon the use of inhibitors, which have been shown to be
toxic to cells (Reaney et al., 2006).
We also found that the increase in proteasomal activity in the PFC
and NAc typically induced by cocaine administration was absent in
S120D KI mice, indicating that the eﬀects of cocaine are occluded since
we found an overall increase in proteasome activity from intact aﬃnity
puriﬁed 26S proteasomes from total brain homogenates in S120D KI
mice (Gonzales and Patrick; data not shown). The PFC and NAc have
previously been implicated in behavioral sensitization (Robinson and
Kolb, 1997; Thomas et al., 2001; Steketee, 2003). Enduring morpho-
logical alterations were found in NAc and PFC neurons following am-
phetamine-induced sensitization including an increase in the length of
dendrites, density of spines, and number of branched spines (Robinson
and Kolb, 1997). These results highlight the long-lasting adaptations to
synaptic connectivity that result from repeated experience with drugs of
abuse. Speciﬁcally how these morphological changes contribute to
addiction is unknown. Interestingly, the UPS has previously been shown
to be implicated in spine stability and recently Rpt6 phosphorylation
and proteasome function have been shown to regulate the formation of
new dendritic spines (Hamilton et al., 2012). One intriguing possibility
that may account for the present ﬁndings is that activity-dependent
Rpt6 phosphorylation at serine 120 contributes to the structural
changes that occur following repeated psychostimulant administration.
Potentially, constitutively active phosphorylation at this site may in-
terfere with the stimulant-induced morphological changes, thus pre-
venting sensitization.
5. Conclusions
Surprisingly, we observed no locomotor sensitization of the Rpt6
S120D phospho-mimetic animals to cocaine, indicating this sensitiza-
tion is occluded by the inability to modulate proteasome activity
through its phosphorylation. Our results show that regulation of the
proteasome itself to be important in cocaine-induced sensitization.
However, future understanding of downstream UPS targets involved in
these paradigms will be essential to better understand the molecular
mechanisms underlying cocaine sensitization.
Funding and disclosure
This work was supported by NIH Grant NS060847 (G.N.P.), Grant
P50-GMO85764 from the Center for Systems Biology (G.N.P.), NIDA
grant DA020041 (S.G.A.), and NSF Graduate Research Fellowship
(K.K.H.). The authors declare no competing ﬁnancial interests.
Acknowledgements
We thank the research assistants and animal technicians in the
Patrick and Anagnostaras labs for their technical assistance. We also
thank Sora Shin of the Dr. Byungkook Lim lab, UCSD for performing the
qPCR.
References
Anagnostaras, S.G., Robinson, T.E., 1996. Sensitization to the psychomotor stimulant
eﬀects of amphetamine: modulation by associative learning. Behav. Neurosci. 110,
1397–1414.
Anagnostaras, S., Schallert, T., Robinson, T.E., 2002. Memory processes governing am-
phetamine-induced psychomotor sensitization. Neuropsychopharmacology 26,
703–715.
Anderson, S., Famous, K.R., Sadri-Vakili, G., Kumaresan, V., Schmidt, H.D., Bass, C.E.,
Terwilliger, E.F., Cha, J.H.J., Pierce, R.C., 2008. CaMKII: a biochemical bridge
linking accumbens dopamine and glutamate systems in cocaine seeking. Nat.
Neurosci. 11, 344–353.
Besche, H.C., Goldberg, A.L., 2012. Aﬃnity puriﬁcation of mammalian 26S proteasomes
using an ubiquitin-like domain. Methods Mol. Biol. 832, 423–432.
Bingol, B., Wang, C.F., Arnott, D., Cheng, D., Peng, J., Sheng, M., 2010.
Autophosphorylated CaMKIIalpha acts as a scaﬀold to recruit proteasomes to den-
dritic spines. Cell 140, 567–578.
Carmack, S.A., Kim, J.S., Sage, J.R., Thomas, A.W., Skillicorn, K.N., Anagnostaras, S.G.,
2013. The competitive NMDA receptor antagonist CPP disrupts cocaine-induced
conditioned place preference, but spares behavioral sensitization. Behav. Brain Res.
239, 155–163.
Djakovic, S.N., Schwarz, L.A., Barylko, B., DeMartino, G.N., Patrick, G.N., 2009.
Regulation of the proteasome by neuronal activity and calcium/calmodulin-depen-
dent protein kinase II. J. Biol. Chem. 284, 26655–26665.
Djakovic, S.N., Marquez-Lona, E.M., Jakawich, S.K., Wright, R., Chu, C., Sutton, M.A.,
Patrick, G.N., 2012. Phosphorylation of Rpt6 regulates synaptic strength in hippo-
campal neurons. J. Neurosci. 32, 5126–5131.
Hamilton, A.M., Zito, K., 2013. Breaking it down: the ubiquitin proteasome system in
neuronal morphogenesis. Neural Plast. 2013, 196848.
Hamilton, A.M., Oh, W.C., Vega-Ramirez, H., Stein, I.S., Hell, J.W., Patrick, G.N., Zito, K.,
2012. Activity-dependent growth of new dendritic spines is regulated by the pro-
teasome. Neuron 74, 1023–1030.
Hernandez, P., Sadeghian, K., Kelley, A.E., 2002. Early consolidation of instrumental
learning requires protein synthesis in the nucleus accumbens. Nat. Neurosci. 5,
1327–1331.
Hershko, A., Ciechanover, A., 1998. The ubiquitin system. Annu. Rev. Biochem. 67,
425–479.
Howell, K.K., Monk, B.R., Carmack, S.A., Mrowczynski, O.D., Clark, R.E., Anagnostaras,
S.G., 2014. Inhibition of PKC disrupts addiction-related memory. Front. Behav.
Neurosci. 8.
Kisselev, A.F., Goldberg, A.L., 2005. Monitoring activity and inhibition of 26S protea-
somes with ﬂuorogenic peptide substrates. Methods Enzymol. 398, 364–378.
Mabb, A.M., Ehlers, M.D., 2010. Ubiquitination in postsynaptic function and plasticity.
Annu. Rev. Cell Dev. Biol. 26, 179–210.
Massaly, N., Dahan, L., Baudonnat, M., Hovnanian, C., Rekik, K., Solinas, M., David, V.,
Pech, S., Zajac, J.M., Roullet, P., Mouledous, L., Frances, B., 2013. Involvement of
protein degradation by the ubiquitin proteasome system in opiate addictive beha-
viors. Neuropsychopharmacology 38, 596–604.
Reaney, S., Johnston, L.C., Langston, W.J., Di Monte, D.A., 2006. Comparison of the
neurotoxic eﬀects of proteasomal inhibitors in primary mesencephalic cultures. Exp.
Neurol. 202, 434–440.
Ren, Z., Liu, M.M., Xue, Y.X., Ding, Z.B., Xue, L.F., Zhai, S.D., Lu, L., 2013. A critical role
for protein degradation in the nucleus accumbens core in cocaine reward memory.
Neuropsychopharmacology 38, 778–790.
Robinson, T., Berridge, K.C., 2008. The incentive sensitization theory of addiction: some
current issues. Philos. Trans. R. Soc. 363, 3137–3146.
Robinson, T., Kolb, B., 1997. Persistent structural modiﬁcations in nucleus accumbens
and prefrontal cortex neurons produced by previous experience with amphetamine.
J. Neurosci. 17, 8491–8497.
Russo, S.J., Dietz, D.M., Dumitriu, D., Morrison, J.H., Malenka, R.C., Nestler, E.J., 2010.
The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus
accumbens. Trends Neurosci. 33, 267–276.
Schafe, G., LeDoux, J.E., 2000. Memory consolidation of auditory Pavlovian fear con-
ditioning requires protein synthesis and protein kinase A in the amygdala. J.
Neurosci. 20, RC96.
Schmittgen, T.D., Livak, K.J., 2008. Analyzing real-time PCR data by the comparative
C(T) method. Nat. Protoc. 3, 1101–1108.
Steketee, J., 2003. Neurotransmitter systems of the medial prefrontal cortex: potential
role in sensitization to psychostimulants. Brain Res. Rev. 41, 203–228.
Thomas, M., Beurrier, C., Bonci, A., Malenka, R.C., 2001. Long-term depression in the
nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat.
Neurosci. 4, 1217–1223.
Volkow, N.D., Fowler, J.S., Wang, G.J., Goldstein, R.Z., 2002. Role of dopamine, the
frontal cortex and memory circuits in drug addiction: insight from imaging studies.
Neurobiol. Learn. Mem. 78, 610–624.
F.R. Gonzales et al. Molecular and Cellular Neuroscience 88 (2018) 62–69
69
